Global Research Collaboration for Infectious Disease Preparedness

Last updated

The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseases. GloPID-R is intended to be a means for facilitating communication and collaboration between its member bodies, as opposed to a funding or disaster response entity. [1] Its secretariat is funded by the European Union through its Horizon 2020 initiative. [2]

Contents

History

GloPID-R was launched in February 2013 in Brussels, Belgium on the recommendation of the Heads of International Research Organizations (HIROs). [3] [4]

On February 11-12, 2020, GloPID-R co-hosted an event with the World Health Organization's R&D Blueprint called “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap”. [5] Participants in this conference identified a number of key research priorities which served as the basis on which funding decisions were made in response to the COVID-19 pandemic. [3] [6]

Membership

GloPID-R's membership is made up of national research funding agencies, academic research institutes and philanthropic organizations. The World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and European and Developing Countries Clinical Trials Partnership (EDCCTP) serve as observers. [3]

As of February 2023, GloPID-R's member organizations were as follows: [7]

Members and Representatives
OrganizationRepresentativeNation
Academy of Scientific Research & TechnologyAmr Radwan Egypt
African Academy of Sciences Thomas Kariuki Kenya
ANRS Emerging Infectious Diseases Yazdan Yazdanpanah France
Bill & Melinda Gates Foundation David W. Vaughn United States
Butantan Institute Alexander Precioso Brazil
Canadian Institutes of Health Research Charu Kaushic Canada
Carlos III Health Institute Tomás López-Peña Spain
Coalition for Epidemic Preparedness Innovations Richard Hatchett, Frederik KristensenGlobal
United States Department of Health and Human Services Chris HassellUnited States
ESSENCE on Health Research InitiativeGarry AslanyanGlobal
European and Developing Countries Clinical Trials Partnership Pauline BeattieGlobal
European Commission Barbara Kerstiens European Union
European Research Infrastructure on Highly Pathogenic AgentsJonathan EwbankEuropean Union
Instituto Fiocruz Marco KriegerBrazil
National Research and Innovation Fund for Development (FONRID)Hamidou H. Tamboura Burkina Faso
Fund for Science, Technology and Innovation (FONSTI)Annette Ouattara Côte-d'Ivoire
Foreign, Commonwealth and Development Office Jo Mulligan United Kingdom
Gavi, the Vaccine Alliance Marta Tufet-BayonaGlobal
Federal Ministry of Education and Research Manuela Rehtanz Germany
Global Outbreak Alert and Response Network Gail CarsonGlobal
International Development Research Centre Samiran PandaCanada
Japan Agency for Medical Research and Development Shoji Miyagawa Japan
Medical Research Council (MRC) Anna KinseyUnited Kingdom
Italian Ministry of Health Gaetano Guglielmi Italy
National Council for Science and Technology Eugène Mutimura Rwanda
National Council of Science and Technology (CONACYT)Juan José Serrato Mexico
National Health and Medical Research Council Anne Kelso Australia
Thai National Institute of Health Aree Thattiyaphong Thailand
National Research Foundation of Korea Choong-Min Ryu South Korea
Netherlands Organisation for Health Research and Development (ZONMW)Suzanne Verver Netherlands
Pasteur NetworkNadia KhelefFrance
Research Council of Norway Thomas Hansteen Norway
São Paulo Research Foundation Rui MacielBrazil
Secretariat of Government of Science, Technology and Productive InnovationDiego Galeano Argentina
South African Medical Research Council Jeffrey Mphahlele South Africa
Swiss National Science Foundation Matthias Egger Switzerland
Department of Health and Social Care Lucy Chappell United Kingdom
Wellcome Trust Jeremy Farrar United Kingdom
World Health Organization Ana-Maria Henao-RestrepoGlobal

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Widespread, often global, epidemic of severe infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Canadian Institutes of Health Research</span> Canadian federal agency

The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.

<span class="mw-page-title-main">European Centre for Disease Prevention and Control</span> Agency of the European Union

The European Centre for Disease Prevention and Control (ECDC) is an agency of the European Union (EU) whose mission is to strengthen Europe's defences against infectious diseases. It covers a wide spectrum of activities, such as: surveillance, epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training, international relations, health communication, and the scientific journal Eurosurveillance. The centre was established in 2004 and is headquartered in Solna, Sweden.

Ross Upshur is a Canadian physician and researcher. He is a professor at the Dalla Lana School of Public Health of the University of Toronto in Toronto, Canada, and heads its public health division.

Heads of International Research Organizations (HIROs) is an organization composed of directors of International Research Organizations. It was established by Harold Varmus in 1998. Representatives from United States, Canada, China, EU, India, South Africa, and South Korea. The members include director of NIH, Wellcome Trust, Korea Health Industry Development Institute (KHIDI).

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

<span class="mw-page-title-main">Coalition for Epidemic Preparedness Innovations</span> Public-private organization for vaccine development

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

<span class="mw-page-title-main">Nevan Krogan</span> Canadian molecular and systems biologist

Nevan J. Krogan is a Canadian molecular and systems biologist. He is a professor and the Director of the Quantitative Biosciences Institute (QBI) at the University of California San Francisco (UCSF), as well as a senior investigator at the J. David Gladstone Institutes.

<span class="mw-page-title-main">Alliance for Biosecurity</span>

The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases. It is headquartered in Washington DC.

<span class="mw-page-title-main">Disease X</span> Placeholder infectious disease name from the WHO

Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen. Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses, instead of just individual strains, thus improving WHO capability to respond to unforeseen strains. In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X.

<span class="mw-page-title-main">Syra Madad</span> American pathogen preparedness expert

Syra Madad is an American pathogen preparedness expert and infectious disease epidemiologist. Madad is the Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals where she is part of the executive leadership team which oversees New York City's response to the Coronavirus disease 2019 pandemic in the city's 11 public hospitals. She was featured in the Netflix documentary series Pandemic: How to Prevent an Outbreak and the Discovery Channel documentary The Vaccine: Conquering COVID.

<span class="mw-page-title-main">Michael J. Ryan (doctor)</span> Irish doctor and Chief Executive Director of the WHO Health Emergencies Programme

Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.

<span class="mw-page-title-main">Peter Daszak</span> British zoologist

Peter Daszak is a British zoologist, consultant and public expert on disease ecology, in particular on zoonosis. He is the president of EcoHealth Alliance, a nonprofit non-governmental organization that supports various programs on global health and pandemic prevention. He is also a member of the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. He lives in Suffern, New York.

The COVID-19 Immunity Task Force (CITF) is one of the Government of Canada's early efforts to track the 2020 coronavirus pandemic. An external, dedicated secretariat was established in order to maximize the efficiency of the CITF's work.

<span class="mw-page-title-main">Access to COVID-19 Tools Accelerator</span> G20 COVID-19 global initiative

The Access to COVID-19 Tools Accelerator, or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. A call to action was published simultaneously by the World Health Organization (WHO) on 24 April. As of January 2022, it was the largest international effort to achieve equitable access to COVID-19 health technologies.

<span class="mw-page-title-main">BlueDot</span>

BlueDot Inc. is a Canadian artificial intelligence software company based in Toronto, Ontario. The company's flagship product is Insights, a software-as-service used to map the spread of infectious diseases.

<span class="mw-page-title-main">Marion Koopmans</span> Dutch virologist

Maria Petronella Gerarda Koopmans is a Dutch virologist who is Head of the Erasmus MC Department of Viroscience. Her research considers emerging infectious diseases, noroviruses and veterinary medicine. In 2018 she was awarded the Netherlands Organisation for Scientific Research (NWO) Stevin Prize. She serves on the scientific advisory group of the World Health Organization.

<span class="mw-page-title-main">John Nkengasong</span> Cameroonian-American virologist

John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.

<span class="mw-page-title-main">Lothar H. Wieler</span> German veterinarian, microbiologist, and the current president of the Robert Koch Institute

Lothar Heinz Wieler is a German veterinarian and microbiologist who served as president of the Robert Koch Institute (RKI) from 2015 to 2023. In this capacity, he advised the German Federal and State Governments on topics of public health, especially infection hazards, and on the containment of the COVID-19 pandemic.

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is an international research initiative based in Oxford, England. It is hosted at the Nuffield Department of Medicine within the University of Oxford and led by the Epidemic diseases Research Group Oxford (ERGO). ISARIC is funded by the Bill & Melinda Gates Foundation, Foreign, Commonwealth and Development Office, and Wellcome Trust.

References

  1. Plank, Irene. "Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)" (PDF). European Commission. Retrieved 2016-02-28.
  2. "European Commission : CORDIS : Projects & Results Service : Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Secretariat". European Commission . Archived from the original on 2023-01-29. Retrieved 2016-02-23.
  3. 1 2 3 Kaushic, Charu; Boily-Larouche, Geneviève (2020-12-17). "Coordinating research on pandemic preparedness and rapid response". Open Access Government. Archived from the original on 2023-05-01. Retrieved 2023-05-08.
  4. "Our milestones – Global research collaboration for infectious disease preparedness". Global Research Collaboration for Infectious Disease Preparedness . Archived from the original on 2023-03-30. Retrieved 2023-05-08.
  5. "Global research and innovation forum to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency". World Health Organization . 2020-02-06. Archived from the original on 2022-07-18. Retrieved 2023-02-09.
  6. Kaushic, Charu (2020-03-26). "Message from the Scientific Director: The CIHR response to the COVID-19 pandemic - CIHR". Canadian Institutes of Health Research . Archived from the original on 2023-05-01. Retrieved 2023-05-08.
  7. "Members". GLOPID-R. Archived from the original on 2022-12-07. Retrieved 2016-02-28.